Last reviewed · How we verify
NUSINERSEN SODIUM
At a glance
| Generic name | NUSINERSEN SODIUM |
|---|---|
| Modality | Oligonucleotide |
| Phase | FDA-approved |
| First approval | 2016 |
Approved indications
Common side effects
Key clinical trials
- Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)
- Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |